Maj-Hes A - Search Results

1

Comprehensive analysis of serum chromogranin A and neuron-specific enolase levels in localized and castration-resistant prostate cancer.

Szarvas T, Csizmarik A, Fazekas T, Hüttl A, Nyirády P, Hadaschik B, Grünwald V, Püllen L, Jurányi Z, Kocsis Z, Shariat SF, Sevcenco S, Maj-Hes A, Kramer G. Szarvas T, et al. Among authors: maj hes a. BJU Int. 2021 Jan;127(1):44-55. doi: 10.1111/bju.15086. Epub 2020 May 14. BJU Int. 2021. PMID: 32314509

2

Matrix metalloproteinase 7, soluble Fas and Fas ligand serum levels for predicting docetaxel resistance and survival in castration-resistant prostate cancer.

Szarvas T, Sevcenco S, Módos O, Keresztes D, Nyirády P, Csizmarik A, Ristl R, Puhr M, Hoffmann MJ, Niedworok C, Hadaschik B, Maj-Hes A, Shariat SF, Kramer G. Szarvas T, et al. BJU Int. 2018 Oct;122(4):695-704. doi: 10.1111/bju.14415. Epub 2018 Jun 20. BJU Int. 2018. PMID: 29802777

3

The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate Cancer.

Darr C, Krafft U, Hadaschik B, Tschirdewahn S, Sevcenco S, Csizmarik A, Nyirady P, Küronya Z, Reis H, Maj-Hes A, Shariat SF, Kramer G, Szarvas T. Darr C, et al. Urol Int. 2018;101(1):65-73. doi: 10.1159/000489891. Epub 2018 Jun 27. Urol Int. 2018. PMID: 29949801

4

Apparent diffusion coefficient values obtained by unenhanced MRI predicts disease-specific survival in bladder cancer.

Sevcenco S, Maj-Hes AB, Hruby S, Ponhold L, Heinz-Peer G, Rauchenwald M, Marszalek M, Klingler HC, Polanec S, Baltzer PAT. Sevcenco S, et al. Clin Radiol. 2018 Oct;73(10):881-885. doi: 10.1016/j.crad.2018.05.022. Epub 2018 Jun 30. Clin Radiol. 2018. PMID: 29970242

5

Claros System: A Rapid Microfluidics-Based Point-of-Care System for Quantitative Prostate Specific Antigen Analysis from Finger-Stick Blood.

Maj-Hes A, Sevcenco S, Szarvas T, Kramer G. Maj-Hes A, et al. Adv Ther. 2019 Apr;36(4):916-922. doi: 10.1007/s12325-019-0888-0. Epub 2019 Feb 18. Adv Ther. 2019. PMID: 30778908

6

The prognostic value of serum MMP-7 levels in prostate cancer patients who received docetaxel, abiraterone, or enzalutamide therapy.

Szarvas T, Csizmarik A, Váradi M, Fazekas T, Hüttl A, Nyirády P, Hadaschik B, Grünwald V, Tschirdewahn S, Shariat SF, Sevcenco S, Maj-Hes A, Kramer G. Szarvas T, et al. Among authors: maj hes a. Urol Oncol. 2021 May;39(5):296.e11-296.e19. doi: 10.1016/j.urolonc.2020.09.005. Epub 2020 Oct 9. Urol Oncol. 2021. PMID: 33046366 Free article.

7

Multiple Docetaxel Retreatments Without Prednisone for Metastatic Castration-Resistant Prostate Cancer in the Docetaxel-Only Era: Effects on PSA Kinetics and Survival.

Maj-Hes A, Szarvas T, Sevcenco S, Kramer G. Maj-Hes A, et al. Adv Ther. 2021 Jul;38(7):3831-3841. doi: 10.1007/s12325-021-01778-8. Epub 2021 May 27. Adv Ther. 2021. PMID: 34043207 Free PMC article.

8

Proteome profiling of enzalutamide-resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration-resistant prostate cancer.

Csizmarik A, Keresztes D, Nagy N, Bracht T, Sitek B, Witzke K, Puhr M, Tornyi I, Lázár J, Takács L, Kramer G, Sevcenco S, Maj-Hes A, Jurányi Z, Hadaschik B, Nyirády P, Szarvas T. Csizmarik A, et al. Among authors: maj hes a. Int J Cancer. 2022 Oct 15;151(8):1405-1419. doi: 10.1002/ijc.34159. Epub 2022 Jun 21. Int J Cancer. 2022. PMID: 35689436 Free PMC article.

9

Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer.

Csizmarik A, Nagy N, Keresztes D, Váradi M, Bracht T, Sitek B, Witzke K, Puhr M, Tornyi I, Lázár J, Takács L, Kramer G, Sevcenco S, Maj-Hes A, Hadaschik B, Nyirády P, Szarvas T. Csizmarik A, et al. Among authors: maj hes a. Prostate Cancer Prostatic Dis. 2023 Aug 26. doi: 10.1038/s41391-023-00713-y. Online ahead of print. Prostate Cancer Prostatic Dis. 2023. PMID: 37634036

10

[Chronic inflammation as promotor and treatment target in benign prostate hyperplasia (BPH) and in prostate cancer].

Kramer G, Mitteregger D, Maj-Hes A, Sevchenco S, Brozek W. Kramer G, et al. Urologe A. 2007 Sep;46(9):1095-6. doi: 10.1007/s00120-007-1444-0. Urologe A. 2007. PMID: 17671777 German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page